-+ 0.00%
-+ 0.00%
-+ 0.00%

ZAI LAB ANNOUNCES NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) APPROVAL OF AUGTYRO™ (REPOTRECTINIB) FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

路透·01/06/2026 12:30:00

登錄查看新聞詳情